We are live on ! Find out more
OM icon

Outset Medical

152 hedge funds and large institutions have $1.26B invested in Outset Medical in 2022 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 44 increasing their positions, 44 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,263% more call options, than puts

Call options by funds: $9.99M | Put options by funds: $297K

67% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 24

66% more capital invested

Capital invested by funds: $760M → $1.26B (+$503M)

10% more funds holding

Funds holding: 138152 (+14)

0.14% more ownership

Funds ownership: 6.63%6.77% (+0.14%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 44

Holders
152
Holders Change
+14
Holders Change %
+10.14%
% of All Funds
2.44%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
40
Increased
44
Reduced
44
Closed
24
Calls
$9.99M
Puts
$297K
Net Calls
+$9.69M
Net Calls Change
+$11.3M
Name Holding Trade Value Shares
Change
Change in
Stake
N
26
Nuveen
North Carolina
$9.4M +$4.31M +15,283 +170%
RPAM
27
Rhenman & Partners Asset Management
Sweden
$9.3M +$376K +1,333 +6%
Charles Schwab
28
Charles Schwab
California
$9.27M +$163K +577 +2%
Fidelity International
29
Fidelity International
Bermuda
$9.18M -$36.1K -128 -0.5%
D.E. Shaw & Co
30
D.E. Shaw & Co
New York
$8.02M +$5.84M +20,700 New
Allspring Global Investments
31
Allspring Global Investments
North Carolina
$7.47M -$11.3M -39,922 -67%
PAMP
32
Polar Asset Management Partners
Ontario, Canada
$7.33M +$5.34M +18,933 New
WP
33
Woodline Partners
California
$5.14M -$912K -3,235 -20%
Citadel Advisors
34
Citadel Advisors
Florida
$5.03M -$6.26M -22,188 -63%
Goldman Sachs
35
Goldman Sachs
New York
$4.88M +$1.87M +6,642 +111%
New York State Common Retirement Fund
36
New York State Common Retirement Fund
New York
$4.73M +$846 +3 +0%
Ameriprise
37
Ameriprise
Minnesota
$4.62M +$46.2K +164 +1%
Deutsche Bank
38
Deutsche Bank
Germany
$4.51M +$373K +1,322 +13%
Invesco
39
Invesco
Georgia
$3.97M +$2.32M +8,212 +403%
SAM
40
Sectoral Asset Management
Quebec, Canada
$3.61M +$1.69M +6,000 +180%
IAIM
41
Industrial Alliance Investment Management
Quebec, Canada
$3.56M -$834K -2,959 -24%
BC
42
Brookfield Corp
Ontario, Canada
$3.5M +$2.55M +9,049 New
N
43
Natixis
France
$3.5M +$1.74M +6,179 +216%
Voloridge Investment Management
44
Voloridge Investment Management
Florida
$3.31M +$174K +616 +8%
CS
45
Candriam SCA
Luxembourg
$3.23M -$582K -2,064 -20%
Amundi
46
Amundi
France
$3.1M -$129K -459 -6%
State of Wisconsin Investment Board
47
State of Wisconsin Investment Board
Wisconsin
$2.94M -$254K -900 -11%
UBS AM
48
UBS AM
Illinois
$2.82M +$336K +1,191 +20%
Neuberger Berman Group
49
Neuberger Berman Group
New York
$2.8M +$2.04M +7,219 New
Assenagon Asset Management
50
Assenagon Asset Management
Luxembourg
$2.55M

OM Hedge Fund Activity: Q4 2022 in Review

152 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Outset Medical (OM) for Q4 2022, worth a combined $1.26B — up 66% from $760M a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new OM positions and 24 closed out — a net gain of 16 holders — while 44 added to existing stakes and 44 trimmed.

The largest buyer was Barclays, adding an estimated $8.27M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $11.6M sold.

  • 152 institutional investors held Outset Medical (OM) as of Q4 2022, up from 138 in Q3 2022.
  • Funds reported $1.26B of Outset Medical stock for Q4 2022, up 66% quarter-over-quarter.
  • 40 funds opened new Outset Medical positions in Q4 2022 and 24 closed out, a net change of +16 holders.
  • The largest Outset Medical buyer in Q4 2022 was Barclays, an estimated $8.27M added.
  • The largest Outset Medical seller in Q4 2022 was PFM Health Sciences, an estimated $11.6M sold.

Based on aggregated 13F filings for Q4 2022.